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Stroke and atrial fibrillation
To the Editor: I write in response to two consecutive papers 
published in the SAMJ.1,2 The striking feature in both was complete 
lack of reference to the presence or absence of atrial fibrillation. 
More than 30% of strokes relate to atrial fibrillation, depending on 
the report referred to. Although not directly applicable to the article 
by Walker et al.,1 it would have been reasonable for them to mention 
the presence or absence of atrial fibrillation in the same way as levels 
of blood pressure are reported. 
In the paper by de Villiers et al.,2 surely recurrent stroke is a major 
determinant of outcome following stroke? In the uncoagulated 
patient with atrial fibrillation the risk of recurrent stroke is extremely 
high. The implications of this are self-evident.
Traditionally, in sub-Saharan Africa a large emphasis has 
been placed on the danger of uncontrolled or poorly controlled 
hypertension. In the same light, the presence or absence of atrial 
fibrillation (particularly in the presence of valvular disease or 
heart failure) needs to be recognised, since the correct treatment 
for this is oral anticoagulant therapy with vitamin K antagonists. 
Documentation of the incidence of atrial fibrillation in paroxysmal 
or permanent atrial fibrillation is therefore essential in the setting of 
stroke and its long term outcome.3-5
By ‘spreading the word’, there is little doubt that great improvement 
in terms of prevention of either first or second episodes of stroke in 
relation to atrial fibrillation can be achieved.
I W P Obel
Specialist Cardiologist 
Milpark Hospital
Johannesburg
proobel@netactive.co.za
Dr De Villiers replies: In our study atrial fibrillation as a cause of 
stroke was not specifically mentioned, as the aetiology of stroke was not 
the focus of the paper. Of the 196 patients 11.2% (N=22) had cardio-
embolic stroke, of whom 54.5% (N=12) were in atrial fibrillation. The 
outcomes for the patients with cardio-embolic stroke were worse than 
those for the whole cohort, with a 50% mortality at 6 months and 
45.4% of survivors having severe disability (modified Rankin scores of 
4 or 5) at 6 months in those with cardio-embolic stroke compared with 
a 6-month post-discharge mortality of 23% and 22% severe residual 
disability for the cohort as a whole. The point that patients with atrial 
fibrillation have a high risk of stroke recurrence is important, and what 
is particularly concerning in this study is that only 9% (N=2) of patients 
were on anticoagulation at follow-up.
Professor Walker replies: We thank Dr Obel for his response to our 
article. Atrial fibrillation is part of the scoring system for the Allen 
scoring system. We did not report the number of cases fulfilling each of 
the criteria laid out in the Siriraj or Allen scoring systems, because our 
intention was to focus on the key messages of the article. However, we 
have reported how many cases in the Hai (4 of 93 who had ECGs) and 
Dar-es-Salaam (3 of 39 who had ECGs) demographic surveillance sites 
had atrial fibrillation in an earlier publication from our study.1
We acknowledge the importance of identifying and managing 
patients with atrial fibrillation in the prevention of stroke, though we 
also recognise that the lack, and expense, of monitoring facilities may 
mean that many people cannot receive oral anticoagulants in sub-
Saharan Africa (SSA). We are currently engaged in a study of atrial 
fibrillation in a community in SSA and hope to be able to present our 
findings in the near future. 
Changes to parental consent 
procedures in South Africa – 
implications for school-based 
adolescent sexual health research
To the Editor: How can a researcher protect the rights of adolescents 
who want to take part in school-based sexual health research, 
ensuring that informed consent to participate is properly obtained, 
without hindering the potentially beneficial research itself? In South 
Africa, the National Health Act 2003 (the Act)1 Sections 71(2) and 
71(3), when enacted, may inadvertently compromise the rights of 
adolescents to benefit from preventive school-based health research, 
rather than protect them from research-related exploitation.
The proposed changes to the Act will require active consent from 
a legal guardian for all research conducted with subjects under 
the age of 18 for so-called ‘therapeutic research’, and both parental 
consent and ministerial consent for ‘non-therapeutic research’. No 
other caregiver or custodian will be able to give consent for a 
child’s participation in research. While current guidelines such as 
the Department of Health’s ‘Ethics in Health Research’2 state that 
adolescents defined as ‘persons who have reached puberty’ are able 
to consent unassisted to research so long as it poses minimal risk and 
is unlikely to be objectionable to parents and community members, 
the National Health Act provides no such leeway.2
We feel that the proposed new guidelines are inappropriate for the 
South African social context. The Act has the potential to prevent 
children without a legal guardian from accessing research that could 
potentially benefit them. This is especially problematic, given that 
those without parents or legal guardians are more vulnerable to early 
sexual debut and contracting HIV.3 The Act may also compromise 
an adolescent’s right to dignity and privacy.4 Confidentiality is 
paramount in research that explores sensitive topics such as sexuality. 
In South Africa, discussions surrounding HIV/AIDS and sex are 
often shrouded in stigma, and parent-child communication about 
these issues is invariably difficult.5 An adolescent who is required to 
confront a parent or guardian about participation in a sexual health 
research study may be vulnerable to violence or reproach.
Students should be allowed to participate in school-based sexual 
health research that recognises and seeks to understand adolescents’ 
unique needs and that develops programmes to promote their 
well-being, even if their parents would choose to deny them access 
on moralistic grounds. In line with other countries, current South 
African ethics guidance requires that any research content is 
examined and approved by relevant research ethics committees 
before it reaches the students. Furthermore, empirical evidence 
has shown that 14-year-olds may be just as competent as adults in 
their ability to provide informed consent in terms of ‘stringent legal 
standards of competency’.6
We suggest that other methods be considered as options for consent 
to participate in school-based adolescent sexual and reproductive 
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